Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells

References

• Prado G, Svoboda RM, Rigel DS. What’s new in melanoma. Dermatol Clin. 2019;37(2):159–168. doi:10.1016/j.det.2018.12.00530850038
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran Pathologic Basis of Disease, Professional Edition e-Book. elsevier health sciences; 2014.
   Google Scholar
• Matthews NH, Li W-Q, Qureshi AA, Weinstock MA, Cho E. Epidemiology of Melanoma. Cutaneous Melanoma: Etiology and Therapy [Internet]. Codon Publications; 2017.
   Google Scholar
• Tavakkoli A, Mahdian V, Razavi BM, Hosseinzadeh H. Review on clinical trials of black seed (Nigella sativa) and its active constituent, thymoquinone. J Pharmacopuncture. 2017;20(3):179. doi:10.3831/KPI.2017.20.02130087794
   PubMed Web of Science ®Google Scholar
• Gholamnezhad Z, Havakhah S, Boskabady MH. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: a review. J Ethnopharmacol. 2016;190:372–386. doi:10.1016/j.jep.2016.06.06127364039
   PubMed Web of Science ®Google Scholar
• Majdalawieh AF, Fayyad MW, Nasrallah GK. Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa. Crit Rev Food Sci Nutr. 2017;57(18):3911–3928. doi:10.1080/10408398.2016.127797128140613
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Khan IA, et al. Thymoquinone: a novel strategy to combat cancer: a review. Biomed Pharmacother. 2018;106:390–402. doi:10.1016/j.biopha.2018.06.15929966985
   PubMed Web of Science ®Google Scholar
• Mostofa A, Hossain MK, Basak D, Sayeed B, Shahdaat M. Thymoquinone as a potential adjuvant therapy for cancer treatment: evidence from preclinical studies. Front Pharmacol. 2017;8:295. doi:10.3389/fphar.2017.0029528659794
   PubMed Web of Science ®Google Scholar
• Kabil N, Bayraktar R, Kahraman N, et al. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer. Breast Cancer Res Treat. 2018;171(3):593–605.29971628
   PubMed Web of Science ®Google Scholar
• Woo CC, Loo SY, Gee V, et al. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway. Biochem Pharmacol. 2011;82(5):464–475. doi:10.1016/j.bcp.2011.05.03021679698
   PubMed Web of Science ®Google Scholar
• Zhang L, Bai Y, Yang Y. Thymoquinone chemosensitizes colon cancer cells through inhibition of NF‑κB. Oncol Lett. 2016;12(4):2840–2845. doi:10.3892/ol.2016.497127698868
   PubMed Web of Science ®Google Scholar
• Samarghandian S, Azimi‐Nezhad M, Farkhondeh T. Thymoquinone‐induced antitumor and apoptosis in human lung adenocarcinoma cells. J Cell Physiol. 2019;234(7):10421–10431. doi:10.1002/jcp.2771030387147
   PubMed Web of Science ®Google Scholar
• Ng WK, Saiful Yazan L, Yap LH, et al. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa). Biomed Res Int. 2015;2015:1–10. doi:10.1155/2015/263131
   Web of Science ®Google Scholar
• Taha M, Sheikh B, Salim L, et al. Thymoquinone induces apoptosis and increase ROS in ovarian cancer cell line. Cell Mol Biol. 2016;62(6):97–101.
   PubMed Web of Science ®Google Scholar
• Kou B, Liu W, Zhao W, et al. Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the GF-β/Smad2/3 signaling pathway. Oncol Rep. 2017;38(6):3592–3598.29039572
   PubMed Web of Science ®Google Scholar
• Sarman H, Bayram R, Benek S. Anticancer drugs with chemotherapeutic interactions with thymoquinone in osteosarcoma cells. Eur Rev Med Pharmacol Sci. 2016;20(7):1263–1270.27097945
   PubMed Web of Science ®Google Scholar
• Alobaedi OH, Talib WH, Basheti IA. Antitumor effect of thymoquinone combined with resveratrol on mice transplanted with breast cancer. Asian Pac J Trop Med. 2017;10(4):400–408. doi:10.1016/j.apjtm.2017.03.02628552110
   PubMed Web of Science ®Google Scholar
• Odeh LH, Talib WH, Basheti IA. Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice. J Cancer Res Ther. 2018;14(9):324. doi:10.4103/0973-1482.235349
   Google Scholar
• Khan A, Aldebasi YH, Alsuhaibani SA, Khan MA. Thymoquinone augments cyclophosphamide-mediated inhibition of cell proliferation in breast cancer cells. Asian Pac J Cancer Prev. 2019;20(4):1153. doi:10.31557/APJCP.2019.20.4.115331030489
   PubMedGoogle Scholar
• Aumeeruddy MZ, Mahomoodally MF. Combating breast cancer using combination therapy with 3 phytochemicals: piperine, sulforaphane, and thymoquinone. Cancer. 2019;125(10):1600–1611. doi:10.1002/cncr.3202230811596
   PubMed Web of Science ®Google Scholar
• Darakhshan S, Pour AB, Colagar AH, Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol Res. 2015;95:138–158. doi:10.1016/j.phrs.2015.03.01125829334
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Arfuso F, Kumar AP, et al. Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn. Pharmacol Res. 2018;129:357–364. doi:10.1016/j.phrs.2017.11.02329162539
   PubMed Web of Science ®Google Scholar
• Shanmugam MK, Ahn KS, Hsu A, et al. Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis. Front Pharmacol. 2018;9:1294.30564115
   PubMed Web of Science ®Google Scholar
• Khan MA, Tania M, Fu J. Epigenetic role of thymoquinone: impact on cellular mechanism and cancer therapeutics. Drug Discov Today. 2019;24(12):2315–2322. doi:10.1016/j.drudis.2019.09.00731541714
   PubMed Web of Science ®Google Scholar
• Feng L-M, Wang X-F, Huang Q-X. Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway. J Biosci. 2017;42(4):547–554. doi:10.1007/s12038-017-9708-329229873
   PubMed Web of Science ®Google Scholar
• Elmowafy EM, Tiboni M, Soliman ME. Biocompatibility, biodegradation and biomedical applications of poly (lactic acid)/poly (lactic-co-glycolic acid) micro and nanoparticles. Int J Pharm Investig. 2019;1–34.
   Google Scholar
• Ramazani F, Chen W, van Nostrum CF, et al. Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: state-of-the-art and challenges. Int J Pharm. 2016;499(1–2):358–367. doi:10.1016/j.ijpharm.2016.01.02026795193
   PubMed Web of Science ®Google Scholar
• Allahyari M, Mohit E. Peptide/protein vaccine delivery system based on PLGA particles. Hum Vaccin Immunother. 2016;12(3):806–828. doi:10.1080/21645515.2015.110280426513024
   PubMed Web of Science ®Google Scholar
• Zhu S, Xing H, Gordiichuk P, Park J, Mirkin CA. PLGA spherical nucleic acids. Adv Mater. 2018;30(22):1707113. doi:10.1002/adma.201707113
   Web of Science ®Google Scholar
• Kalyane D, Raval N, Maheshwari R, Tambe V, Kalia K, Tekade RK. Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer. Mater Sci Eng. 2019;98:1252–1276. doi:10.1016/j.msec.2019.01.066
   Google Scholar
• Liu Y, Sun D, Fan Q, et al. The enhanced permeability and retention effect based nanomedicine at the site of injury. Nano Res. 2020;1–6.
   Web of Science ®Google Scholar
• Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev. 2011;63(3):170–183. doi:10.1016/j.addr.2010.10.00820965219
   PubMed Web of Science ®Google Scholar
• Danhier F, Vroman B, Lecouturier N, et al. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J Control Release. 2009;140(2):166–173. doi:10.1016/j.jconrel.2009.08.01119699245
   PubMed Web of Science ®Google Scholar
• Doolaanea A, Harun AF, Mohamed F. Quantification of Nigella sativa oil (NSO) from biodegradable PLGA nanoparticles using FTIR spectroscopy. Int J Pharm Pharm Sci. 2014;6(10):228–232.
   Google Scholar
• Azad AK, Al-Mahmood SMA, Chatterjee B, Wan Sulaiman WMA, Elsayed TM, Doolaanea AA. Encapsulation of black seed oil in alginate beads as a ph-sensitive carrier for intestine-targeted drug delivery: in vitro, in vivo and ex vivo study. Pharmaceutics. 2020;12(3):219. doi:10.3390/pharmaceutics12030219
   PubMed Web of Science ®Google Scholar
• Doolaanea AA, Mansor NI, Nor NHM, Shafri MABM, Mohamed F. Comparative assessment of plasmid DNA delivery by encapsulation within or adsorbed on poly (D, L-lactide-coglycolide) nanoparticles. Trop J Pharm Res. 2018;17(1):1–10. doi:10.4314/tjpr.v17i1.1
   Web of Science ®Google Scholar
• Salmani JM, Asghar S, Lv H, Zhou J. Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules. 2014;19(5):5925–5939. doi:10.3390/molecules1905592524815311
   PubMed Web of Science ®Google Scholar
• Choi M, Briancon S, Andrieu J, Min S, Fessi H. Effect of freeze-drying process conditions on the stability of nanoparticles. Dry Technol. 2004;22(1–2):335–346. doi:10.1081/DRT-120028238
   Web of Science ®Google Scholar
• Albanese A, Chan WC. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano. 2011;5(7):5478–5489. doi:10.1021/nn200749621692495
   PubMed Web of Science ®Google Scholar
• Moore TL, Rodriguez-Lorenzo L, Hirsch V, et al. Nanoparticle colloidal stability in cell culture media and impact on cellular interactions. Chem Soc Rev. 2015;44(17):6287–6305. doi:10.1039/C4CS00487F26056687
   PubMed Web of Science ®Google Scholar
• Park K. Prevention of nanoparticle aggregation during freeze-drying. J Control Release. 2017;248:153. doi:10.1016/j.jconrel.2017.01.03828190423
   PubMed Web of Science ®Google Scholar
• Allison SD, Molina MC, Anchordoquy TJ. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim Biophys Acta. 2000;1468(1–2):127–138. doi:10.1016/S0005-2736(00)00251-011018658
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy L, Moorthy R, Umapathy D, Kannan M, Ganesan N, Arockiam A. Encapsulation of doxorubicin in PLGA nanoparticles enhances cancer therapy. Clin Oncol. 2017;2:1325.
   Google Scholar
• Xiao XY, Zhu YX, Bu JY, Li GW, Zhou JH, Zhou SP. Evaluation of neuroprotective effect of thymoquinone nanoformulation in the rodent cerebral ischemia-reperfusion model. Biomed Res Int. 2016;2016:2571060. doi:10.1155/2016/257106027725936
   PubMed Web of Science ®Google Scholar
• Sharma N, Madan P, Lin S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharm Sci. 2016;11(3):404–416. doi:10.1016/j.ajps.2015.09.004
   Web of Science ®Google Scholar
• Gamucci O, Bertero A, Malvindi MA, et al. Detection of fluorescent nanoparticle interactions with primary immune cell subpopulations by flow cytometry. J Vis Exp. 2014;85.
   Web of Science ®Google Scholar
• Salvati A, Nelissen I, Haase A, et al. Quantitative measurement of nanoparticle uptake by flow cytometry illustrated by an interlaboratory comparison of the uptake of labelled polystyrene nanoparticles. NanoImpact. 2018;9:42–50. doi:10.1016/j.impact.2017.10.004
   Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505–522. doi:10.1016/j.jconrel.2012.01.04322353619
   PubMed Web of Science ®Google Scholar
• Liu H, Liu T, Li L, et al. Size dependent cellular uptake, in vivo fate and light–heat conversion efficiency of gold nanoshells on silica nanorattles. Nanoscale. 2012;4(11):3523–3529. doi:10.1039/c2nr30396e22552611
   PubMed Web of Science ®Google Scholar
• Ohta S, Inasawa S, Yamaguchi Y. Real time observation and kinetic modeling of the cellular uptake and removal of silicon quantum dots. Biomaterials. 2012;33(18):4639–4645. doi:10.1016/j.biomaterials.2012.03.02922475529
   PubMed Web of Science ®Google Scholar
• Rothen-Rutishauser B, Kuhn DA, Ali Z, et al. Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine (Lond). 2014;9(5):607–621. doi:10.2217/nnm.13.2423738633
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamamoto H, Kawashima Y. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery. Eur J Pharm Biopharm. 2010;75(2):218–224. doi:10.1016/j.ejpb.2010.03.01320332026
   PubMed Web of Science ®Google Scholar
• Benga G. Basic studies on gene therapy of human malignant melanoma by use of the human interferon beta gene entrapped in cationic multilamellar liposomes. 1. Morphology and growth rate of six melanoma cell lines used in transfection experiments with the human interferon beta gene. J Cell Mol Med. 2001;5(4):402–408.12067474
   PubMed Web of Science ®Google Scholar
• Hatiboglu MA, Kocyigit A, Guler EM, et al. Thymoquinone induces apoptosis in B16-F10 melanoma cell through inhibition of p-STAT3 and inhibits tumor growth in a murine intracerebral melanoma model. World Neurosurg. 2018;114:e182–e90. doi:10.1016/j.wneu.2018.02.13629510292
   PubMed Web of Science ®Google Scholar
• Xiong S, George S, Yu H, Damoiseaux R, France B, Ng KW. Size influences the cytotoxicity of poly (lactic-co-glycolic acid) (PLGA) and titanium dioxide (TiO(2)) nanoparticles. Arch Toxicol. 2013;87(6):1075–1086. doi:10.1007/s00204-012-0938-822983807
   PubMed Web of Science ®Google Scholar
• Chen H, Xie LQ, Qin J, et al. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Colloids Surf B Biointerfaces. 2016;138:1–9. doi:10.1016/j.colsurfb.2015.11.03326638176
   PubMed Web of Science ®Google Scholar
• Nafee N, Schneider M, Schaefer UF, Lehr C-M. Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile. Int J Pharm. 2009;381(2):130–139. doi:10.1016/j.ijpharm.2009.04.04919450671
   PubMed Web of Science ®Google Scholar
• Welch MJ, Hawker CJ, Wooley KL. The advantages of nanoparticles for PET. J Nucl Med. 2009;50(11):1743–1746. doi:10.2967/jnumed.109.06184619837751
   PubMed Web of Science ®Google Scholar